CCNY expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.734000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.704180E-01
Normal-vs-Stage2
1.867780E-01
Normal-vs-Stage3
3.048200E-02
Normal-vs-Stage4
9.559000E-01
Stage1-vs-Stage2
8.895400E-01
Stage1-vs-Stage3
1.398610E-01
Stage1-vs-Stage4
1.720000E-01
Stage2-vs-Stage3
2.367000E-01
Stage2-vs-Stage4
1.457230E-01
Stage3-vs-Stage4
3.048400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.607440E-01
Normal-vs-AfricanAmerican
8.238800E-01
Normal-vs-Asian
4.178000E-02
Caucasian-vs-AfricanAmerican
1.065650E-01
Caucasian-vs-Asian
3.672000E-01
AfricanAmerican-vs-Asian
3.756400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.882790E-01
Normal-vs-Female
1.632810E-01
Male-vs-Female
3.884600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.871170E-01
Normal-vs-Age(41-60Yrs)
2.579600E-01
Normal-vs-Age(61-80Yrs)
1.737390E-01
Normal-vs-Age(81-100Yrs)
1.320370E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.733400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.560400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.844600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.064500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.535500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.066400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.179600E-01
Normal-vs-Daily Drinker
6.513700E-02
Normal-vs-Weekly Drinker
7.658300E-02
Normal-vs-Occasional Drinker
2.122400E-01
Normal-vs-Social Drinker
2.602600E-01
Non Drinker-vs-Daily Drinker
4.629000E-01
Non Drinker-vs-Weekly Drinker
9.181400E-01
Non Drinker-vs-Occasional Drinker
7.816000E-01
Non Drinker-vs-Social Drinker
7.513600E-01
Daily Drinker-vs-Weekly Drinker
3.249200E-01
Daily Drinker-vs-Occasional Drinker
2.346000E-01
Daily Drinker-vs-Social Drinker
2.392400E-01
Weekly Drinker-vs-Occasional Drinker
8.104200E-01
Weekly Drinker-vs-Social Drinker
7.615000E-01
Occasional Drinker-vs-Social Drinker
9.401000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.737600E-01
Normal-vs-Grade 2
6.421200E-01
Normal-vs-Grade 3
2.728800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.864560E-01
Grade 1-vs-Grade 3
3.395200E-01
Grade 1-vs-Grade 4
3.737600E-01
Grade 2-vs-Grade 3
9.486000E-01
Grade 2-vs-Grade 4
6.421200E-01
Grade 3-vs-Grade 4
2.728800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.609700E-02
Normal-vs-NonDiabetic
1.557210E-01
Diabetic-vs-NonDiabetic
6.613800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.159840E-01
Normal-vs-NoPancreatitis
1.613170E-01
Pancreatitis-vs-NoPancreatitis
6.661600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.145160E-01
Normal-vs-N1
2.114000E-01
N0-vs-N1
5.047600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.565600E-01
Normal-vs-TP53-NonMutant
2.124400E-01
TP53-Mutant-vs-TP53-NonMutant
5.719600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
